NUVEEN QUALITY MUNICIPAL INC (NAD) Fundamental Analysis & Valuation

NYSE:NADUS67066V1017

Current stock price

11.705 USD
+0.1 (+0.82%)
Last:

This NAD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NAD Profitability Analysis

1.1 Basic Checks

  • In the past year NAD was profitable.
  • In the past year NAD had a positive cash flow from operations.
  • Of the past 5 years NAD 4 years were profitable.
  • Each year in the past 5 years NAD had a positive operating cash flow.
NAD Yearly Net Income VS EBIT VS OCF VS FCFNAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA 0.28%
ROE 0.31%
ROIC 1.88%
ROA(3y)-2.23%
ROA(5y)-0.17%
ROE(3y)-2.31%
ROE(5y)-0.19%
ROIC(3y)2%
ROIC(5y)2.08%
NAD Yearly ROA, ROE, ROICNAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • In the last couple of years the Profit Margin of NAD has remained more or less at the same level.
  • NAD's Operating Margin has declined in the last couple of years.
  • In the last couple of years the Gross Margin of NAD has declined.
Industry RankSector Rank
OM 49.78%
PM (TTM) 6.06%
GM 49.35%
OM growth 3Y-14.2%
OM growth 5Y-5.66%
PM growth 3Y23.91%
PM growth 5Y0.05%
GM growth 3Y-14.27%
GM growth 5Y-5.74%
NAD Yearly Profit, Operating, Gross MarginsNAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200 -300

5

2. NAD Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for NAD remains at a similar level compared to 1 year ago.
  • NAD has more shares outstanding than it did 5 years ago.
  • NAD has a worse debt/assets ratio than last year.
NAD Yearly Shares OutstandingNAD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NAD Yearly Total Debt VS Total AssetsNAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • NAD has an Altman-Z score of 3.56. This indicates that NAD is financially healthy and has little risk of bankruptcy at the moment.
  • The Debt to FCF ratio of NAD is 1.49, which is an excellent value as it means it would take NAD, only 1.49 years of fcf income to pay off all of its debts.
  • A Debt/Equity ratio of 0.08 indicates that NAD is not too dependend on debt financing.
  • Although NAD's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.49
Altman-Z 3.56
ROIC/WACCN/A
WACCN/A
NAD Yearly LT Debt VS Equity VS FCFNAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 2.10 indicates that NAD has no problem at all paying its short term obligations.
  • NAD has a Quick Ratio of 2.10. This indicates that NAD is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
NAD Yearly Current Assets VS Current LiabilitesNAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. NAD Growth Analysis

3.1 Past

  • The earnings per share for NAD have decreased strongly by -76.00% in the last year.
  • Measured over the past years, NAD shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.25% on average per year.
  • The Revenue has been growing slightly by 3.20% in the past year.
  • Measured over the past years, NAD shows a small growth in Revenue. The Revenue has been growing by 1.65% on average per year.
EPS 1Y (TTM)-76%
EPS 3Y26.41%
EPS 5Y-1.25%
EPS Q2Q%-123.57%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y2.07%
Revenue growth 5Y1.65%
Sales Q2Q%2.68%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAD Yearly Revenue VS EstimatesNAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

0

4. NAD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 195.08, NAD can be considered very expensive at the moment.
  • NAD is valuated expensively when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 195.08
Fwd PE N/A
NAD Price Earnings VS Forward Price EarningsNAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 10.76
EV/EBITDA N/A
NAD Per share dataNAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. NAD Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.72%, NAD is a good candidate for dividend investing.
  • NAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.72%

5.2 History

  • The dividend of NAD has a limited annual growth rate of 0.96%.
  • NAD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NAD has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.96%
Div Incr Years2
Div Non Decr Years2
NAD Yearly Dividends per shareNAD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 1435.71% of the earnings are spent on dividend by NAD. This is not a sustainable payout ratio.
  • NAD's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP1435.71%
EPS Next 2YN/A
EPS Next 3YN/A
NAD Yearly Income VS Free CF VS DividendNAD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M -800M
NAD Dividend Payout.NAD Dividend Payout, showing the Payout Ratio.NAD Dividend Payout.PayoutRetained Earnings

NAD Fundamentals: All Metrics, Ratios and Statistics

NUVEEN QUALITY MUNICIPAL INC

NYSE:NAD (4/30/2026, 1:08:48 PM)

11.705

+0.1 (+0.82%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)01-05
Earnings (Next)07-06
Inst Owners20.76%
Inst Owner Change0.34%
Ins Owners0.03%
Ins Owner Change0.23%
Market Cap2.73B
Revenue(TTM)231.00M
Net Income(TTM)14.00M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 6.72%
Yearly Dividend0.67
Dividend Growth(5Y)0.96%
DP1435.71%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 195.08
Fwd PE N/A
P/S 11.83
P/FCF 10.76
P/OCF 10.76
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)0.06
EY0.51%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.09
FCFY9.29%
OCF(TTM)1.09
OCFY9.29%
SpS0.99
BVpS19.1
TBVpS19.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.07841 (-56.61%)
Profitability
Industry RankSector Rank
ROA 0.28%
ROE 0.31%
ROCE 2.38%
ROIC 1.88%
ROICexc 1.88%
ROICexgc 1.88%
OM 49.78%
PM (TTM) 6.06%
GM 49.35%
FCFM 109.91%
ROA(3y)-2.23%
ROA(5y)-0.17%
ROE(3y)-2.31%
ROE(5y)-0.19%
ROIC(3y)2%
ROIC(5y)2.08%
ROICexc(3y)2.02%
ROICexc(5y)2.09%
ROICexgc(3y)2.02%
ROICexgc(5y)2.09%
ROCE(3y)2.54%
ROCE(5y)2.63%
ROICexgc growth 3Y-7.79%
ROICexgc growth 5Y-4.06%
ROICexc growth 3Y-7.78%
ROICexc growth 5Y-4.06%
OM growth 3Y-14.2%
OM growth 5Y-5.66%
PM growth 3Y23.91%
PM growth 5Y0.05%
GM growth 3Y-14.27%
GM growth 5Y-5.74%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.49
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.42
Cash Conversion N/A
Profit Quality 1813.43%
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 3.56
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76%
EPS 3Y26.41%
EPS 5Y-1.25%
EPS Q2Q%-123.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y2.07%
Revenue growth 5Y1.65%
Sales Q2Q%2.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.48%
EBIT growth 3Y-12.43%
EBIT growth 5Y-4.1%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.67%
FCF growth 3Y-18.8%
FCF growth 5Y-8.41%
OCF growth 1Y-10.67%
OCF growth 3Y-18.8%
OCF growth 5Y-8.41%

NUVEEN QUALITY MUNICIPAL INC / NAD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NUVEEN QUALITY MUNICIPAL INC (NAD) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NAD.


What is the valuation status for NAD stock?

ChartMill assigns a valuation rating of 0 / 10 to NUVEEN QUALITY MUNICIPAL INC (NAD). This can be considered as Overvalued.


How profitable is NUVEEN QUALITY MUNICIPAL INC (NAD) stock?

NUVEEN QUALITY MUNICIPAL INC (NAD) has a profitability rating of 2 / 10.


What is the valuation of NUVEEN QUALITY MUNICIPAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NUVEEN QUALITY MUNICIPAL INC (NAD) is 195.08 and the Price/Book (PB) ratio is 0.61.


Is the dividend of NUVEEN QUALITY MUNICIPAL INC sustainable?

The dividend rating of NUVEEN QUALITY MUNICIPAL INC (NAD) is 4 / 10 and the dividend payout ratio is 1435.71%.